DK1379262T3 - Fremgangsmåde til fremstilling af et med aktive stoffer höjt beriget ekstrakt af Ginkgo Biloba-blade - Google Patents

Fremgangsmåde til fremstilling af et med aktive stoffer höjt beriget ekstrakt af Ginkgo Biloba-blade

Info

Publication number
DK1379262T3
DK1379262T3 DK02761922T DK02761922T DK1379262T3 DK 1379262 T3 DK1379262 T3 DK 1379262T3 DK 02761922 T DK02761922 T DK 02761922T DK 02761922 T DK02761922 T DK 02761922T DK 1379262 T3 DK1379262 T3 DK 1379262T3
Authority
DK
Denmark
Prior art keywords
ginkgo biloba
biloba leaves
ethyl acetate
liquid
extract
Prior art date
Application number
DK02761922T
Other languages
Danish (da)
English (en)
Inventor
Beng-Poon Teng
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK1379262T3 publication Critical patent/DK1379262T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02761922T 2001-04-10 2002-04-09 Fremgangsmåde til fremstilling af et med aktive stoffer höjt beriget ekstrakt af Ginkgo Biloba-blade DK1379262T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0104942A FR2823116B1 (fr) 2001-04-10 2001-04-10 Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs
PCT/FR2002/001219 WO2002083158A1 (fr) 2001-04-10 2002-04-09 Procede de preparation d'un extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs

Publications (1)

Publication Number Publication Date
DK1379262T3 true DK1379262T3 (da) 2005-02-14

Family

ID=8862215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02761922T DK1379262T3 (da) 2001-04-10 2002-04-09 Fremgangsmåde til fremstilling af et med aktive stoffer höjt beriget ekstrakt af Ginkgo Biloba-blade

Country Status (20)

Country Link
US (1) US7048954B2 (ja)
EP (1) EP1379262B1 (ja)
JP (1) JP4416404B2 (ja)
KR (1) KR100876233B1 (ja)
CN (1) CN1245167C (ja)
AT (1) ATE278411T1 (ja)
AU (1) AU2002307981B2 (ja)
CA (1) CA2443302C (ja)
CZ (1) CZ299652B6 (ja)
DE (1) DE60201525T8 (ja)
DK (1) DK1379262T3 (ja)
ES (1) ES2230512T3 (ja)
FR (1) FR2823116B1 (ja)
HK (1) HK1066164A1 (ja)
HU (1) HUP0303797A3 (ja)
NZ (1) NZ528571A (ja)
PL (1) PL204867B1 (ja)
PT (1) PT1379262E (ja)
RU (1) RU2297235C2 (ja)
WO (1) WO2002083158A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040031772A (ko) 2001-07-11 2004-04-13 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 은행의 잎 및 약제학적 분말로부터 테르펜트리락톤(징코라이드, 빌로바라이드)을 분리하는 방법
US7145021B2 (en) 2002-03-29 2006-12-05 The Trustees Of Columbia University In The City Of New York Analogs of terpene trilactones from Ginkgo biloba and related compounds and uses thereof
JP2004307396A (ja) * 2003-04-07 2004-11-04 Kao Corp デオドラント剤
WO2005021496A2 (en) 2003-08-27 2005-03-10 The Trustees Of Columbia University In The City Of New York Synthesis of derivatives of ginkgolide c
WO2005046829A2 (en) 2003-11-12 2005-05-26 The Trustees Of Columbia University In The City Of New York Separation of ginkgolides and bilobalide from g. biloba
EP1537874B1 (de) * 2003-12-04 2007-06-13 Cognis IP Management GmbH Verfahren zur Herstellung von Extrakten des Ginkgo Biloba
WO2006004386A1 (es) * 2004-07-02 2006-01-12 Rojas Castaneda Patricia Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson
CN1891242B (zh) * 2005-07-06 2012-01-04 徐州技源天然保健品有限公司 一种从银杏叶提取物中脱除多环芳烃的生产工艺
FR2904222A1 (fr) * 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
CZ299802B6 (cs) * 2006-10-12 2008-11-26 Kalvoda@Jaroslav Príprava zálivky obsahující extrakt z náprstníku cerveného, extrakt z jinanu dvoulalocného a dusicnan draselný, a její vliv na rostliny
HUE041715T2 (hu) * 2007-12-21 2019-05-28 Dr Willmar Schwabe Gmbh & Co Kg Ginkgo biloba levél-kivonat alkalmazása
FR2926994B1 (fr) * 2008-02-06 2010-08-27 Sod Conseils Rech Applic Nouveau procede pour la preparation d'extraits de ginkgo biloba
EP2459205A1 (en) * 2009-07-28 2012-06-06 Velleja Research SRL Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN110893183A (zh) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044659C (zh) * 1987-06-30 1999-08-18 吴羽化学工业株式会社 含有唑类衍生物的农业和园艺用的农药组合物
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
JPH02193907A (ja) * 1989-01-19 1990-07-31 Daicel Chem Ind Ltd イチョウエキスの製法
KR940002796B1 (ko) * 1989-06-16 1994-04-02 주식회사 선경인더스트리 은행잎에서 징코라이드를 분리 및 정제하는 방법
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
GB9107425D0 (en) * 1991-04-09 1991-05-22 Scras Preparation of ginkgolide b
GB9408044D0 (en) * 1994-04-22 1994-06-15 Sod Conseils Rech Applic Conversion of ginkgolide c to ginkgolide b
DE19756848C2 (de) * 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
CN1124275C (zh) * 2000-06-02 2003-10-15 天津大学 由银杏叶或银杏叶浸膏制备药物银杏内酯a、b的方法
EP1163908B1 (en) * 2000-06-16 2004-05-06 Linnea S.A. Water-soluble complex of an extract of Ginkgo Bilboa, process for the preparation thereof and composition comprising the same
KR20040031772A (ko) * 2001-07-11 2004-04-13 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 은행의 잎 및 약제학적 분말로부터 테르펜트리락톤(징코라이드, 빌로바라이드)을 분리하는 방법

Also Published As

Publication number Publication date
AU2002307981B2 (en) 2006-11-23
HUP0303797A3 (en) 2005-05-30
DE60201525T8 (de) 2006-08-24
FR2823116A1 (fr) 2002-10-11
KR100876233B1 (ko) 2008-12-26
ATE278411T1 (de) 2004-10-15
ES2230512T3 (es) 2005-05-01
JP4416404B2 (ja) 2010-02-17
HK1066164A1 (en) 2005-03-18
FR2823116B1 (fr) 2004-11-19
CA2443302C (fr) 2012-09-18
RU2003132470A (ru) 2005-03-10
CA2443302A1 (fr) 2002-10-24
DE60201525T2 (de) 2006-03-02
KR20030087068A (ko) 2003-11-12
PT1379262E (pt) 2005-02-28
EP1379262B1 (fr) 2004-10-06
PL366938A1 (en) 2005-02-07
US7048954B2 (en) 2006-05-23
CZ299652B6 (cs) 2008-10-01
EP1379262A1 (fr) 2004-01-14
NZ528571A (en) 2005-06-24
CZ20033055A3 (cs) 2004-06-16
US20040109907A1 (en) 2004-06-10
CN1501806A (zh) 2004-06-02
DE60201525D1 (de) 2004-11-11
RU2297235C2 (ru) 2007-04-20
PL204867B1 (pl) 2010-02-26
CN1245167C (zh) 2006-03-15
WO2002083158A1 (fr) 2002-10-24
JP2004538263A (ja) 2004-12-24
HUP0303797A2 (hu) 2004-03-29

Similar Documents

Publication Publication Date Title
DK1379262T3 (da) Fremgangsmåde til fremstilling af et med aktive stoffer höjt beriget ekstrakt af Ginkgo Biloba-blade
Apati et al. Herbal remedies of Solidago—correlation of phytochemical characteristics and antioxidative properties
EP1755629A1 (de) Ginkgo biloba extrakt und verfahren zu seiner herstellung
RU2007143632A (ru) Способ получения экстракта из гинкго и экстрат гинкго билоба
Choi et al. Extraction conditions for phenolic compounds with antioxidant activities from white rose petals
JPH02184626A (ja) 血小板凝集抑制剤
CN106349038B (zh) 一种制备麝香酮的方法
KR101839491B1 (ko) 어성초 추출물의 추출방법 및 이를 이용한 화장료 조성물
CN111944165B (zh) 一种多酚类酪氨酸酶抑制剂及其提取方法和应用
CN108653202A (zh) 一种清眸组合物、包含其的眼液及其制备方法
CN109549880A (zh) 一种啤酒花美白提取液的制备方法
CN105193699B (zh) 一种复方玫瑰精油面膜
KR101070708B1 (ko) 보령산 머드 추출물의 추출방법 및 그 추출물을 함유하는 미백기능성 화장료 조성물
JPH11290438A (ja) 消臭剤組成物
JPH03227985A (ja) イチョウ葉からフラボノイドを高含有する抽出物の簡易な製造法
KR940018077A (ko) 화장료
CN109528819B (zh) 香青兰提取物在制备降尿酸药物中的用途
JPH02193907A (ja) イチョウエキスの製法
CN101780122A (zh) 一种水溶性银杏提取物的制备方法
CN108904343A (zh) 一种延缓衰老的银杏叶组合物及其制备方法与应用
CN1099294C (zh) 一种银杏注射液的制备方法
CN106726891A (zh) 金花茶沐浴露的生产方法
JP2006273817A (ja) 活性炭処理梅肉エキスを含有する皮膚外用剤
KR940013519A (ko) 은행잎으로부터 유효활성물질을 추출 정제하는 방법
KR0120277B1 (ko) 4-히드록시-5-메틸-3[2h]-퓨라논을 함유하는 피부 미백용 조성물